-
My Account
In App
My Account
BSE Live
Oct 24, 16:01Prev. Close
1189.95
Open Price
1166.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Titan Biotech (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 8.24 | 4.36 | 3.77 | 3.49 | 2.59 | |
| Net CashFlow From Operating Activities | 6.92 | 6.20 | 1.56 | -0.04 | 4.91 | |
| Net Cash Used In Investing Activities | -0.94 | -3.74 | -5.24 | -6.85 | -4.77 | |
| Net Cash Used From Financing Activities | -5.87 | -1.55 | 0.26 | 8.49 | 2.01 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.11 | 0.90 | -3.42 | 1.60 | 2.15 | |
| Cash And Cash Equivalents Begin of Year | 1.59 | 0.68 | 4.10 | 2.51 | 0.36 | |
| Cash And Cash Equivalents End Of Year | 1.70 | 1.59 | 0.68 | 4.10 | 2.51 |
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
03.06.2025
Titan Biotech Consolidated March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
02.06.2025
Titan Biotech Standalone March 2025 Net Sales at Rs 35.17 crore, down 11.9% Y-o-Y
28.02.2025
Titan Biotech Consolidated December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
17.02.2025
Titan Biotech Standalone December 2024 Net Sales at Rs 38.28 crore, down 16.75% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017
